PCT application filed for TRPV1-targeting pharmaceutical composition

2020-12-24

Application Number: PCT/KR2020/018895 (2020-12-22)

Applicant: RudaCure Inc.

Title of Invention: Pharmaceutical composition for treating TRPV1 activation-mediated diseases

Priority Number: 10-2020-0007433